Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence

Amber-UI presents a unique and significant opportunity to treat urge and mixed urinary incontinence by targeting the pudendal nerveAmber-UI can sense, interpret, adapt and respond to individual

Related Keywords

United Kingdom ,London ,City Of ,Belgium ,Charles Knowles ,Kostenloser Wertpapierhandel ,Tim Denison ,Frazer Hall Mark ,Aidan Crawley ,Professor Of Urology At Antwerp University ,Bioinduction Limited Bristol ,University Of Oxford ,Oxford Science Enterprises ,Picostim Dyneumo Research Platform ,University Hospital Antwerp Belgium ,Augmenting Urinary Reflex Activity ,University Hospital Antwerp ,Stefan De Wachter ,Bioinduction Limited ,Picostim Deep Brain Stimulation ,Antwerp University ,Chief Scientific Officer ,Emerging Technology ,Chief Medical Officer ,Queen Mary University ,Urinary Incontinence ,Current Neuromodulation ,Mark Swallow ,Sandi Greenwood ,Amber ,Herapeutics ,Nnounces ,Uccessful ,First ,Human ,Implants ,Intelligent ,Closed ,Loop ,Ioelectrical ,Therapy ,Surge ,Ixed ,Urinary ,Incontinence ,